MarginsXMarginsX
Home › Markets › Health Care › RDNT

RadNet Inc. (RDNT)

RDNT trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$76.89
+0.61% on the day
Market cap
$6.1B
Mid cap
Revenue · 2025
$2.0B
+11.5% on 2024
Net income · 2025
-$18.7M
-0.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/790526/000162828026013337/0001628280-26-013337-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerRDNT on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000790526
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.0B
Net income-$18.7M
Operating income$62.0M
Net margin-0.9%
Operating margin3.0%
Revenue growth+11.5%
Cash$767.2M
Total assets$3.8B
P/E (computed)Net income was not positive
P/S (computed)3.0×

Warning signs

Cash runway
Cash-flow positive
$750.6M cash at September 30, 2026
Share count, 1 year
+2.1%
2025-11-07 to 2026-11-05 · +16.0% over 3 years
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
-$12.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$750.6M cash; operating cash flow $87.0M a quarter.Report 2026-09-30
Shares outstanding78,774,892 (2026-11-05); 77,146,342 a year earlier; 67,894,705 three years earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2025-12-04
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Los Angeles, California, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $12.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$638.3M$4.2M$90.6M$750.6M$1.3B$2.4B10-Q 2026-11-09
Q2 2026
2026-06-30
$622.7M$7.5M$94.1M$726.3M$1.3B$2.3B10-Q 2026-08-10
Q1 2026
2026-03-31
$575.6M-$33.5M$79.0M$455.3M$1.1B$2.1B10-Q 2026-05-11
Q4 2025
2025-12-31
$547.7M-$597K$84.2M$767.2M$1.1B$2.0B10-K 2026-03-02
Q3 2025
2025-09-30
$522.9M$5.4M$52.8M$804.7M$1.1B$2.0B10-Q 2026-11-09
Q2 2025
2025-06-30
$498.2M$14.5M$120.3M$833.2M$1.1B$1.9B10-Q 2026-08-10
Q1 2025
2025-03-31
$471.4M-$37.9M$41.5M$717.3M$1.0B$1.9B10-Q 2026-05-11
Q4 2024
2024-12-31
$477.1M$5.3M$42.5M$740.0M$1.0B$1.8B10-K 2026-03-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B72026-08-14
Latest annual report10-K2026-03-02
Latest quarterly / interim10-Q2026-11-09
Latest current report
FORM 8-K
8-K2026-11-09
Latest proxy
FORM DEFA 14A
DEFA14A2026-04-20

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.6%
1 month+6.9%
3 months-1.2%
Year to date+7.1%
1 year+4.0%
From 52-week high-9.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
CAICaris Life Sciences Inc.$21.00-8.85%$6.0B
CONConcentra Group Holdings Parent Inc.$43.44+2.09%$5.5B
GRALGRAIL Inc. Common Stock$105.60-8.88%$4.7B
BLLNBillionToOne Inc.$96.31-8.41%$4.6B
HSICHenry Schein Inc.$84.96-1.46%$9.4B
CDNACareDx Inc.$73.72-5.34%$3.9B
OSCROscar Health Inc.$31.33+0.90%$9.7B
ACHCAcadia Healthcare Company Inc.$38.70+2.44%$3.6B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier